Eurobio Scientific SA

Price Chart

Risk-Adjusted Performance

Eurobio Scientific SA (ALERS) Price Performance

Eurobio Scientific SA (ALERS) trades on Euronext Paris in EUR. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at EUR24.20, up 0.83% from the previous close.

Over the past year, ALERS has traded between a low of EUR20.60 and a high of EUR25.70. The stock has lost 1.0% over this period. It is currently 5.8% below its 52-week high.

Eurobio Scientific SA has a market capitalization of $241.64M, with a price-to-earnings ratio of 109.09.

About Eurobio Scientific SA

Eurobio Scientific Société anonyme engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and oncology. It commercializes media for the transportation and preservation of cornea grafts, as well as a device to facilitate the corresponding surgery; AlloMap, for heart transplant monitoring; cell culture media, molecular biology reagents, and proprietary antibodies; TQS (Tetanus Quick Stick) for the evaluation of patients' immune status against tetanus; and EBX molecular biology range, which includes a range of tests for identifying various pathogens responsible for infectious diseases. The company also develops other diagnostic products using molecular biology. The company was formerly known as Diaxonhit and changed its name to Eurobio Scientific Société anonyme in June 2018. Eurobio Scientific Société anonyme was incorporated in 1997 and is headquartered in Les Ulis, France.

Compare Eurobio Scientific SA

Side-by-side comparison against top Healthcare peers.